Intravenous (IV) Solutions

Intravenous (IV) Solutions

Global Intravenous (IV) Solutions Market to Reach $16 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$16 Billion by 2027, growing at aCAGR of 6.8% over the period 2020-2027. Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$11 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.9 Billion, While China is Forecast to Grow at 8.4% CAGR
The Intravenous (IV) Solutions market in the U.S. is estimated at US$3.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 8.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Select Competitors (Total 67 Featured) -

  • Amanta Healthcare
  • Anhui Medipharm Co., LTD.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen Ag
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited.
  • Vifor Pharma Management Ltd.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Pandemic Affects Demand for Intravenous Solutions
Elective Surgeries Report Roller-Coaster Ride Amid COVID-19, Affecting Demand for IV Solutions
COVID-19 Induced YOY Decline in Heart Surgery Volumes in the US in 2020
COVID-19 Results in Colossal Backlog of Elective Surgeries & Extended Waiting Times
Intravenous (IV) Solutions – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
An Introduction to Intravenous (IV) Solutions
Types of Intravenous Solutions
Global Market Prospects & Outlook
TPN Emerges as the Largest Segment in the IV Solutions Market
Single Dose Amino Acid Solutions: The Major Nutrient Type
Developed Economies Lead, Developing Regions to Propel Future Growth
Competition
World Brands
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
Daily Requirements for Adults (Male and Female) by Nutrient Type
Energy Requirements by Age and Gender
Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
Rising Cancer Incidence and Need for Nutritional Support
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
Number of New Cancer Cases and Deaths (in Million) by Region for 2020
Alarming Rise in Diabetes Incidence Worldwide
World Diabetes and Population Statistics (2019, 2030 & 2045)
World Diabetes Prevalence (2000-2045)
Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
Unrelenting Threat of HIV/AIDS Infection
Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020
Number of AIDS-Related Deaths (in Thousands) by Region for 2018
Nutritional Management of Patients with Neurological Diseases
Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
Growing Numbers of Pre-term Births Drives Demand for IV Solutions
Top Countries Ranked by Most Number of Preterm Births
Countries with Highest Preterm Birth Rates: Number of Preterm Births Per 100 Live Births by Top Countries
Demand Rises for Home Intravenous Nutritional Therapies
Premixed IV Nutrition: A Step towards Safer Medication Practices
Premixed Formulations Present Efficient Delivery System
Iron Replacement Therapies: Potential for Growth
Growing Demand for Low-Cost Intravenous Nutrition Solutions
COVID-19 Outbreak: Combating Medication Errors in IV Infusion
Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Healthcare Expenditure Creates Conducive Environment
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
Challenges Confronting IV Solutions Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Total Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Total Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Total Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Peripheral Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Single Dose Amino Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Vitamins & Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Parenteral Lipid Emulsion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Other Nutrients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 25: USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: USA Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: USA 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 28: USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: USA 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
CANADA
TABLE 31: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: Canada Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: Canada 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 34: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: Canada Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: Canada 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
JAPAN
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 37: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Japan Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Japan 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 40: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Japan Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Japan 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
CHINA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 43: China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: China Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: China 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 46: China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: China Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: China 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
EUROPE
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 49: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 50: Europe Historic Review for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Europe 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 52: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Europe Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Europe 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 55: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Europe 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
FRANCE
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 58: France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: France Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: France 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 61: France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: France Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: France 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
GERMANY
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 64: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Germany Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Germany 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 67: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Germany Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Germany 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
ITALY
TABLE 70: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Italy Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Italy 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 73: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: Italy Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: Italy 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
UNITED KINGDOM
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 76: UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: UK Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: UK 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 79: UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: UK Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: UK 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
SPAIN
TABLE 82: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Spain Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Spain 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 85: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Spain Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Spain 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
RUSSIA
TABLE 88: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Russia Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Russia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 91: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Russia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Russia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Rest of Europe Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Rest of Europe 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 97: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Rest of Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Rest of Europe 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 101: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 103: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
AUSTRALIA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 109: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: Australia Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: Australia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 112: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Australia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Australia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
INDIA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
TABLE 115: India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: India Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: India 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 118: India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: India Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: India 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 121: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: South Korea Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: South Korea 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 124: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: South Korea Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: South Korea 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 127: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 130: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
LATIN AMERICA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 133: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 134: Latin America Historic Review for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
TABLE 136: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: Latin America Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 139: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: Latin America 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
ARGENTINA
TABLE 142: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Argentina Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: Argentina 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 145: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Argentina Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: Argentina 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
BRAZIL
TABLE 148: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Brazil Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Brazil 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 151: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Brazil Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Brazil 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
MEXICO
TABLE 154: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Mexico Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Mexico 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 157: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Mexico Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: Mexico 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: Rest of Latin America Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: Rest of Latin America 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 163: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: Rest of Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: Rest of Latin America 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
MIDDLE EAST
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 166: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 167: Middle East Historic Review for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
TABLE 169: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: Middle East Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 172: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: Middle East 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
IRAN
TABLE 175: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: Iran Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: Iran 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 178: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Iran Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Iran 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
ISRAEL
TABLE 181: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Israel Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Israel 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 184: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Israel Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Israel 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 187: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 188: Saudi Arabia Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: Saudi Arabia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 190: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Saudi Arabia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: Saudi Arabia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 193: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: UAE Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: UAE 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 196: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: UAE Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: UAE 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 199: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Rest of Middle East Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: Rest of Middle East 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 202: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Rest of Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 204: Rest of Middle East 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
AFRICA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 205: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 206: Africa Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 207: Africa 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
TABLE 208: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 209: Africa Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 210: Africa 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 67

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings